|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.34 SEK | -3.88% |
|
-5.41% | -17.96% |
| 07-20 | SynAct Pharma Draws SEK50 Million from New Financing Facility | MT |
| 07-20 | Synact Pharma secures access to financing of up to €9.0m | FW |
| Market Cap | 1.02B 105M 91.81M 85.23M 78.32M 148M 10.11B 150M 397M 4.95B 393M 385M 17.09B | P/E 2026 * |
-12.8x | P/E 2027 * | -25.1x |
|---|---|---|---|---|---|
| Enterprise Value | 998M 103M 90.23M 83.76M 76.97M 145M 9.94B 147M 391M 4.86B 387M 378M 16.8B | EV / Sales 2026 * |
7.19x | EV / Sales 2027 * | 49.2x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | -2.83% | ||
| 1 week | -5.41% | ||
| Current month | -11.92% | ||
| 1 month | +21.97% | ||
| 3 months | +6.31% | ||
| 6 months | -15.73% | ||
| Current year | -17.96% |
| 1 week | 18.3 |  | 20.95 |
| 1 month | 14.38 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/3/26 | Buy | Chairman | 2,750 | 0.0052% | ||
| 9/3/26 | Buy | Executive/Senior Manager | 1,500 | 0.0028% | ||
| 9/3/26 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.88% | -5.41% | -7.11% | -80.48% | 105M | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,037B | |
| +2.00% | +3.49% | +52.22% | +50.20% | 615B | |
| -1.09% | +3.76% | +35.37% | +76.22% | 448B | |
| +2.92% | +3.23% | +31.00% | +25.16% | 326B | |
| -0.36% | +1.46% | +34.30% | +37.73% | 293B | |
| -0.75% | -0.05% | +18.24% | +17.08% | 264B | |
| -2.36% | -7.01% | -29.48% | -43.23% | 216B | |
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | |
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | |
| Average | -0.53% | +0.78% | +22.24% | +35.19% | 355.75B | |
| Weighted average by Cap. | -0.37% | +1.47% | +35.15% | +72.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.32M 12.55M 11.65M 10.7M 20.17M 1.38B 20.46M 54.31M 676M 53.75M 52.59M 2.34B | 21.15M 2.18M 1.91M 1.78M 1.63M 3.07M 211M 3.12M 8.28M 103M 8.19M 8.02M 356M |
| Net income | 52.18M 5.38M 4.72M 4.38M 4.02M 7.58M 520M 7.7M 20.42M 254M 20.21M 19.78M 878M | -26.04M -2.69M -2.36M -2.19M -2.01M -3.79M -259M -3.84M -10.19M -127M -10.09M -9.87M -438M |
| Net Debt | -17.48M -1.8M -1.58M -1.47M -1.35M -2.54M -174M -2.58M -6.84M -85.17M -6.77M -6.63M -294M | 24.86M 2.57M 2.25M 2.09M 1.92M 3.61M 248M 3.67M 9.73M 121M 9.63M 9.42M 418M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | SEK 18.34 | -3.88% | 57,675 |
| 22/07/26 | SEK 19.08 | -1.24% | 239,864 |
| 21/07/26 | SEK 19.32 | +3.87% | 273,494 |
| 20/07/26 | SEK 18.60 | -5.49% | 368,898 |
| 17/07/26 | SEK 19.68 | +0.41% | 130,856 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
